Antifungal susceptibility testing of yeasts

Antimicrobial Susceptibility Testing Protocols

Volumn , Issue , 2007, Pages 173-208

  Espinel Ingroff, Ana ^a   Cantón, Emilia ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123441639     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (28)

1. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard M27-A2, vol. 22, no. 15, 2nd ed., CLSI Document. Clinical and Laboratory Standards Institute, Villanova, PA, 2002.
2. Rodriguez-Tudela, J.L., Barchiesi, F., Bille, J. et al. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts, Clin. Microbiol. Infect., 9, I-VIII, 2003.
3. Pfaller, M.A., Buschelman, M.G., Bale, M.J. et al. Multicenter evaluation of four methods of yeast inoculum preparation, J. Clin. Microbiol., 26, 1437-1441, 1988.
4. Pfaller, M.A., Rinaldi, M.G., Galgiani, J.N. et al. Collaborative investigation of variables in susceptibility testing of yeasts, Antimicrob. Agents Chemother., 34, 1648-1654, 1990.
5. Espinel-Ingroff, A., Kish, C.W., Jr., Kerkering, T.M. et al. Collaborative comparison of broth macroand microdilution antifungal tests, J. Clin. Microbiol., 30, 3138-3145, 1992.
6. Fromtling, R.A., Galgiani, J.N., Pfaller, M.A. et al. Multicenter evaluation of broth macrodilution antifungal susceptibility test for yeasts, Antimicrob. Agents Chemother., 37, 39-45, 1993.
7. Clinical and Laboratory Standards Institute. Quality control minimal inhibitory concentration (MIC) limits for broth microdilution and MIC interpretive breakpoints, approved standard M27-S2, 2nd ed., Clinical and Laboratory Standards Institute, Villanova, PA, 2006.
8. Pfaller, M.A., Bale, M., Buschelman, B. et al. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine, J. Clin. Microbiol., 33, 1104-1107, 1995.
9. Rex, J.H., Pfaller, M.A., Lancaster, M. et al. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of ketoconazole and itracon-azole, J. Clin Microbiol., 34, 816-817, 1996.
10. Barry, A.L., Pfaller, M.A., Brown, S.D. et al. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents, J. Clin. Microbiol., 38, 3457-3459, 2000.
11. Andes, D., Marchillo, K., Stamstad, T., and Conklin, R. In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model, Antimicrob. Agents Chemother., 47, 3165-3169, 2003.
12. Cantón, E., Martín-Mazuelo, E., and Espinel Ingroff, A. Pruebas de sensibilidad antifúngica, in Guia Práctica de Identificación y Diagnóstico en Micología Clínica, Pemán, J., Martín-Mazuelo, E., and Rubio-Calvo, M.C., Eds., Bilbao, Revista Iberoamericana de Micología, 2001, 15.1-15.13.
13. Rex, J.H., Nelson, P.W., Paetznick, V.L. et al. Optimizing the correlation between results of testing in vitro and in therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis, Antimicrob. Agents Chemother., 42, 129-134, 1998.
14. Espinel-Ingroff, A., Barchiesi, F., Cuenca-Estrella, M. et al. Comparison of visual 24 h and spectro-photometric 48 h MICs to CLSI microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: A collaborative study, J. Clin. Microbiol., 41, 4535-4540, 2005.
15. Lozano-Chiu, M., Arikan, S., Paetznick, V.L. et al. Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility, J. Clin Microbiol., 37, 2755-2759, 1999.
16. Espinel-Ingroff, A., Pfaller, M., Erwin, M.E. et al. Interlaboratory evaluation of the Etest method for antifungal susceptibility testing of pathogenic yeasts for five antifungal agents by using casitone agar and solidified RPMI-1640 medium with 2% dextrose, J. Clin. Microbiol., 36, 198-202, 1996.
17. Wanger, A., Mills, K., Nelson, P.W. et al. Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: Enhanced ability to detect amphotericin B-resistant Candida isolates, Antimicrob. Agents Chemother., 39, 2520-2522, 1995.
18. Martín Mazuelos, E., Gutiérrez, M.J., Aller, A.I., et al. A comparative evaluation of E-test and microdilution broth method for fluconazole and itraconazole susceptibility testing of Candida species, J. Antimicrob. Chemother., 43, 477-481, 2000.
19. Espinel-Ingroff, A., Pfaller, M., Messer, S.A. et al. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp. and Cryptococcus spp., and other yeast and yeast-like organisms, J. Clin. Microbiol., 37, 591-595, 1999.
20. Clinical and Laboratory Standards Institute. Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline M44-A, Clinical and Laboratory Standards Institute, Villanova, PA, 2004.
21. Clinical and Laboratory Standards Institute. Zone diameter interpretive standards and corresponding minimal inhibitory concentration (MIC) interpretive breakpoints, supplement M44-S1, Clinical and Laboratory Standards Institute, Wayne, PA, 2006.
22. Barry, A.L., Pfaller, M., Rennie, R.P. et al. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods, Antimicrob. Agents Chemother., 46, 1781-1784, 2002.
23. Barry, A.L. and Brown, S.D. Fluconazole disk diffusion procedure for determining susceptibility of Candida species, J. Clin. Microbiol., 34, 2154-2157, 1996.
24. Cantón, E., Pemán, J., Carrillo-Muñoz, A. et al. Fluconazol susceptibility of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory standards Methods M27-A and two other methods, J. Clin. Microbiol., 37, 2197-2200, 1999.
25. Lee, S., Fung, C., Lee, N. et al. Fluconazole disk diffusion test with methylene-blue and glucose-enriched Mueller-Hinton agar for determining susceptibility of Candida species, J. Clin. Microbiol. 39, 1615-1617, 2001.
26. Meis, J., Petrou, M., Ellis, D. et al. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion, Diag. Microbiol. Infect. Dis., 36, 215-223, 2000.
27. Pfaller, M.A., Boyken, L., Messer, S. et al. Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program, J. Clin. Microbiol., 43, 5208-5213, 2005.
28. Espinel-Ingroff, A. Antifungal susceptibility methods and their potential clinical relevance, Lab. Med., 33, 626-631, 2002.